2012
DOI: 10.1097/rct.0b013e318245c23c
|View full text |Cite
|
Sign up to set email alerts
|

Computed Tomographic Perfusion Imaging for the Therapeutic Response of Chemoembolization for Hepatocellular Carcinoma

Abstract: Computed tomographic perfusion imaging has the ability to evaluate the perfusion changes in HCC after chemoembolization, which can be used to evaluate the therapeutic response of chemoembolization for hepatocellular carcinoma.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
11
1

Year Published

2013
2013
2021
2021

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 35 publications
(14 citation statements)
references
References 15 publications
2
11
1
Order By: Relevance
“…It mostly occurs in patients with chronic hepatitis and cirrhosis. The outcome of patients with untreated HCC is very poor (3). One of the important features in staging is tumor vascularity.…”
Section: Discussionmentioning
confidence: 99%
“…It mostly occurs in patients with chronic hepatitis and cirrhosis. The outcome of patients with untreated HCC is very poor (3). One of the important features in staging is tumor vascularity.…”
Section: Discussionmentioning
confidence: 99%
“…The accurate evaluation of TACE treatment response is conducive to the next step of developing personalized treatment programs. However, assessment of anatomic response in the early post-treatment period has been controversial because the absence of a reduction in tumor size does not mean an absence of response [6] [7] [8]. Magnetic resonance diffusion weighted imaging (DWI) can detect the free diffusion motion of water molecules in living tissue.…”
Section: Introductionmentioning
confidence: 99%
“…Yang et al . [ 56 ] reported that the values of hepatic arterial perfusion, total liver perfusion, and hepatic arterial perfusion index in tumors significantly decreased 4 weeks after TACE in comparison to those before TACE. Previous studies reported reduction in BF or BV after 10-12 days of antiangiogenic therapy without any significant change in tumor size based on RECIST [ Figure 5 ].…”
Section: Introductionmentioning
confidence: 99%